Company Name or Ticker Symbol
Search for other Categories

Aimmune Therapeutics, Inc.  (AIMT)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations


Aimmune Therapeutics, Inc.

AIMT's Financial Statements and Analysis

Aimmune Therapeutics, Inc. increased I. Quarter net loss per share of $-0.52 compare to net loss per share of $-0.37 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.55 realized in previous quarter.

Aimmune Therapeutics's Revenue fell by % in I. Quarter (Mar 31 2017) year on year, to $0 million and declined by sequentially.

Aimmune Therapeutics is
More on AIMT's Income Statement

I. Quarter
Earnings Per Share Revenues
$ -0.52 $  0 Mill
$-0.15     Unch.    
You need to upgrade your Flash Player

Aimmune Therapeutics's in I. Quarter recorded net loss of $-26 million, an increase from net loss of $-16 million in I. Quarter a year ago.

Sequentially net loss advanced

More on AIMT's Growth

In I. Quarter company's net cash and cash equivalents decreased by $-45 million, capital expenditures grew by -19.35%, to $-1 millions compare to same quarter a year ago and rose by -4.26% from IV. Quarter (Dec 31 2016).

More on AIMT's Cash flow Statement

Aimmune Therapeutics, Inc. does not pay out common stock dividend.

In trailing twelve-month period Aimmune Therapeutics, Inc. payed $ -1.47 cash per share, on a free-cash flow basis .

Book value fell by -15.86 % sequentially to $5.29 per share, -49.05% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 5.29 per share from $ 6.28.

Company issued 4.56 million shares or 10.01 % in I. Quarter.

More on AIMT's Dividends
 Market Capitalization (Millions) 1,061
 Shares Outstanding (Millions) 50
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -91
 Cash Flow (TTM) (Millions $) 14
 Capital Exp. (TTM) (Millions $) -7
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com